Nr1h4 Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Nr1h4
nuclear receptor subfamily 1, group H, member 4
MGI:1352464

56 phenotypes from 5 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Nr1h4^tm1.1Gonz/Nr1h4^tm1.1Gonz Tg(Alb1-cre)1Dlr/0 involves: 129X1/SvJ * C57BL/6	increased bile salt level	J:129978
	increased circulating cholesterol level	J:129978
	increased circulating triglyceride level	J:129978
Nr1h4^tm1.1Gonz/Nr1h4^tm1.1Gonz Tg(Vil1-cre)997Gum/0 involves: 129X1/SvJ * C57BL/6 * SJL	abnormal bile salt homeostasis	J:129978
	increased bile salt level	J:129978
Nr1h4^tm1.1Mbj/Nr1h4^tm1.1Mbj B6N.B6-Nr1h4^tm1.1Mbj	abnormal liver perisinusoidal space morphology	J:200842
	abnormal liver physiology	J:200842
	abnormal liver sinusoid morphology	J:200842
	decreased body weight	J:200842
	decreased bone mineral content	J:200842
	decreased bone mineral density	J:200842
	decreased circulating free fatty acids level	J:200842
	decreased circulating glucose level	J:200842
	decreased circulating insulin level	J:200842
	decreased epididymal fat pad weight	J:200842
	decreased interscapular fat pad weight	J:200842
	decreased retroperitoneal fat pad weight	J:200842
	decreased total body fat amount	J:200842
	decreased white fat cell size	J:200842
	enlarged gallbladder	J:200842
	normal growth/size/body region phenotype	J:200842
	hepatic steatosis	J:200842
	normal homeostasis/metabolism phenotype	J:200842
	impaired glucose tolerance	J:200842
	increased bile salt level	J:200842
	increased cecum weight	J:200842
	increased circulating alanine transaminase level	J:200842
	increased circulating bilirubin level	J:200842
	increased circulating cholesterol level	J:200842
	increased energy expenditure	J:200842
	increased fluid intake	J:200842
	increased food intake	J:200842
	increased liver triglyceride level	J:200842
	increased liver weight	J:200842
	increased spleen weight	J:200842
	normal integument phenotype	J:200842
	jaundice	J:200842
	liver degeneration	J:200842
	liver inflammation	J:200842
Nr1h4^tm1.2Auw/Nr1h4^tm1.2Auw involves: 129 * C57BL/6J	abnormal hepatocyte morphology	J:157882
	increased bile salt level	J:157882
	increased hepatocyte apoptosis	J:157882
	increased hepatocyte proliferation	J:157882
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz involves: 129	normal homeostasis/metabolism phenotype	J:118368
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz involves: 129X1/SvJ	abnormal bile composition	J:129978
	increased bile salt level	J:129978
	increased circulating cholesterol level	J:129978
	increased circulating triglyceride level	J:129978
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz involves: 129X1/SvJ * C57BL/6	abnormal liver morphology	J:118204
	enlarged liver	J:118204
	focal hepatic necrosis	J:118204
	increased bile salt level	J:118204
	increased circulating aspartate transaminase level	J:118204
	increased hepatocellular carcinoma incidence	J:118204
	increased hepatocyte apoptosis	J:118204
	increased liver adenoma incidence	J:118204
	increased liver tumor incidence	J:118204
	liver inflammation	J:118204
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz involves: 129X1/SvJ * C57BL/6N	abnormal bile salt homeostasis	J:64792
	abnormal bile salt level	J:64792
	abnormal liver morphology	J:64792
	cachexia	J:64792
	decreased body temperature	J:64792
	decreased body weight	J:121075
	decreased susceptibility to weight gain	J:64792
	enlarged liver	J:121075
	hepatic steatosis	J:64792
	increased bile salt level	J:121075
	increased circulating cholesterol level	J:64792
	increased circulating phospholipid level	J:64792
	increased circulating triglyceride level	J:64792
	increased hepatocellular carcinoma incidence	J:121075
	increased hepatocyte apoptosis	J:121075
	increased hepatocyte proliferation	J:121075
	increased liver adenoma incidence	J:121075
	increased liver cholesterol level	J:64792
	increased liver triglyceride level	J:64792
	increased liver tumor incidence	J:121075
	increased susceptibility to induced morbidity/mortality	J:64792
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz STOCK Nr1h4^tm1Gonz/J	increased circulating alanine transaminase level	J:149005
	increased circulating aspartate transaminase level	J:149005
	increased circulating cholesterol level	J:149005
	increased circulating triglyceride level	J:149005
Nr1h4^tm1Kok/Nr1h4^tm1Kok involves: 129P2/OlaHsd * C57BL/6J	abnormal bile composition	J:86154
	abnormal bile salt homeostasis	J:86154
	abnormal bile secretion	J:86154
	abnormal blood homeostasis	J:86154
	increased bile salt level	J:86154

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24